Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

BVMF/DASA3 stock hub

BVMF/DASA3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVMF/DASA3is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.1B
Brazil Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BVMF/DASA3
In the news

Latest news · BVMF/DASA3

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.1
P25 11.3P50 14.6P75 19.6
Trailing P/En/a
P25 15.2P50 21.5P75 27.3
ROE-15.3
P25 5.3P50 12.3P75 22.5
ROIC7
P25 7P50 12.5P75 22.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVMF/DASA3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
207
Groups with data
11
Currency
BRL
Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Brazil
Country code
BR
Employees
26,255
Employees Change
-21,745%
Employees Change Percent
-45.3
Enterprise value
BRL 10.6B
Exchange
Brazil Stock Exchange
Financial currency
BRL
First seen
2026-05-10
Industry
Diagnostics & Research
Isin
BRDASAACNOR1
Last refreshed
2026-05-10
Market cap
BRL 4.1B
Price
BRL 3.31
Price currency
BRL
Rev Per Employee
425,456.56x
Sector
Healthcare
Sic
8071
Symbol
bvmf/DASA3
Website
https://www.dasa3.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
-27.85%
EV Earnings
-9.21x
EV/EBIT
11.75x
EV/EBITDA
6.19x
EV/FCF
-34.58x
EV/Sales
0.95x
FCF yield
-7.42%
Forward P/E
22.07x
P/B ratio
0.6x
P/S ratio
0.37x
PEG ratio
0.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
9.03%
EBITDA Margin
13.42%
Gross margin
30.38%
Gross Profit
BRL 3.4B
Gross Profit Growth
-19.08%
Gross Profit Growth Q
-23.87%
Gross Profit Growth3 Y
-3.69%
Gross Profit Growth5 Y
14.09%
Net Income
BRL -1.2B
Net Income Growth Years
1%
Pretax Margin
-5.49%
Profit Margin
-10.31%
Profit Per Employee
BRL -43,877
ROA
2.8
Roa5y
2.08
ROCE
7.21
ROE
-15.3
Roe5y
-11.17
ROIC
7.02
Roic5y
4.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

15
MetricValue
Cagr10y
-9.99%
Cagr15y
-11.27%
Cagr1y
94.8%
Cagr20y
-6.59%
Cagr3y
-30.45%
Cagr5y
-43.6%
Div CAGR10
31.16%
Div CAGR5
0%
EPS Growth Years
2
OCF Growth Q
-97.48%
Revenue Growth
-27.1x
Revenue Growth Q
-38.14x
Revenue Growth Years
0x
Revenue Growth3 Y
-5.24x
Revenue Growth5 Y
9.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
BRL 0.5
Assets
BRL 18.6B
Cash
BRL 2.7B
Current Assets
BRL 5.7B
Current Liabilities
BRL 4.6B
Debt
BRL 9.1B
Debt EBITDA
BRL 5.01
Debt Equity
BRL 1.32
Debt FCF
BRL -29.69
Equity
BRL 6.9B
Interest Coverage
0.66
Liabilities
BRL 11.7B
Long Term Assets
BRL 12.9B
Long Term Liabilities
BRL 7.1B
Net Cash
BRL -6.4B
Net Cash By Market Cap
BRL -156
Net Debt EBITDA
BRL 4.3
Net Debt Equity
BRL 0.93
Tangible Book Value
BRL 2.5B
Tangible Book Value Per Share
BRL 1.98
WACC
11.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.24
Inventory Turnover
23.71
Net Working Capital
BRL 786.2M
Quick ratio
1.2
Working Capital
BRL 1.1B
Working Capital Turnover
BRL 5.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.44%
Dividend per share
BRL 0
Last Dividend
BRL 0.3

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-65.11%
1Y total return
94.71%
200-day SMA
2.7
3Y total return
-66.36%
50-day SMA
3.39
50-day SMA vs 200-day SMA
50over200
5Y total return
-94.29%
All Time High
242
All Time High Change
-98.63%
All Time High Date
2021-01-19
All Time Low
1.18
All Time Low Change
180.51%
All Time Low Date
2025-07-30
ATR
0.23
Beta
0.37
Beta1y
0.03
Beta2y
0.58
Ch YTD
-27.09
High
3.53
High52
4.77
High52 Date
2026-01-02
High52ch
-30.61%
Low
3.28
Low52
1.18
Low52 Date
2025-07-30
Low52ch
180.51%
Ma50ch
-2.22%
Price vs 200-day SMA
22.5%
RSI
51.26
RSI Monthly
42.26
RSI Weekly
51.1
Sharpe ratio
1.19x
Sortino ratio
2.08
Total Return
-0.44%
Tr YTD
-27.09
Tr15y
-83.35%
Tr1m
6.09%
Tr1w
1.53%
Tr3m
-21.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
BRL 1B
Operating Income Growth
-7.79
Operating Income Growth3 Y
-0.26
Operating Income Growth5 Y
43.37
Operating margin
9.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
1,175,212,480%
Net Borrowing
-53,230,000
Shares Insiders
5.97%
Shares Institutions
86.28%
Shares Out
1,249,774,542
Shares Qo Q
0%
Shares Yo Y
0.44%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
BRL -327.8M
Average Volume
1,431,575x
Bv Per Share
5.49
CAPEX
BRL -270.4M
Ch10y
-66.9
Ch15y
-84.68
Ch1m
6.09
Ch1w
1.53
Ch1y
94.71
Ch20y
-76.79
Ch3m
-21.56
Ch3y
-66.36
Ch5y
-94.34
Ch6m
63.86
Change
0.61%
Change From Open
0.3
Close
3.29
Days Gap
0.3
Depreciation Amortization
489,987,000
Dollar Volume
5,532,003
Earnings Date
2026-05-12
EBIT
BRL 1B
EBITDA
BRL 1.5B
EPS
BRL -0.92
F Score
4
FCF
BRL -306.7M
FCF EV Yield
-2.89x
FCF Per Share
BRL -0.25
Financing CF
-392,979,000
Fiscal Year End
December
Founded
1,961
Goodwill
3,424,918,000
Income Tax
BRL 522M
Investing CF
1,351,736,000
Is Primary Listing
1
Last Earnings Date
2026-03-26
Last Report Date
2025-12-31
Last Split Date
2010-02-02
Last Split Type
Forward
Ma150
3.16
Ma150ch
4.68%
Ma20
3.23
Ma20ch
2.57%
Net CF
922,408,000
Next Earnings Date
2026-05-12
Open
3.3
Position In Range
12
Ppne
2,663,368,000
Price Date
2026-05-08
Price EBITDA
BRL 2.76
Ptbv Ratio
1.67
Relative Volume
1.21x
Revenue
11,170,362,000x
SBC By Revenue
0.19x
Share Based Comp
21,050,000
Tax By Revenue
4.67x
Tr20y
-74.4%
Tr6m
63.86%
Volume
1,671,300
Z Score
0.65
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BVMF/DASA3 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/DASA3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+94.7%
S&P 500 1Y: n/a
3Y total return
-66.4%
S&P 500 3Y: n/a
5Y total return
-94.3%
S&P 500 5Y: n/a
10Y total return
-65.1%
S&P 500 10Y: n/a
Ownership

Who owns BVMF/DASA3?

Insider, institutional, and short-interest positioning.

Institutional ownership
+86.3%
Share of float held by funds and institutions
Insider ownership
+6.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.4%
Negative means the company is buying back shares.
Technical

BVMF/DASA3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
51.3
Neutral momentum band
Price vs 200-day MA
+22.5%
50/200-day relationship not available
Beta (5Y)
0.37
Less volatile than the market
Sharpe ratio
1.19
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVMF/DASA3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/DASA3 stock rating?

bvmf/DASA3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/DASA3 analysis?

The full report lives at /stocks/bvmf/DASA3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/DASA3?

The latest report frames bvmf/DASA3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/DASA3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.